Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.
Skarlos DV, Kalofonos HP, Fountzilas G, Dimopoulos MA, Pavlidis N, Razis E, Economopoulos T, Pectasides D, Gogas H, Kosmidis P, Bafaloukos D, Klouvas G, Kyratzis G, Aravantinos G. Skarlos DV, et al. Among authors: kosmidis p. Anticancer Res. 2005 Jul-Aug;25(4):3103-8. Anticancer Res. 2005. PMID: 16080573 Free article. Clinical Trial.
Chemotherapy in NSCLC: historical review.
Kosmidis P. Kosmidis P. Lung Cancer. 2002 Dec;38 Suppl 3:S19-22. doi: 10.1016/s0169-5002(02)00261-1. Lung Cancer. 2002. PMID: 12468139 Review.
hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients.
Apessos A, Mihalatos M, Danielidis I, Kallimanis G, Agnantis NJ, Triantafillidis JK, Fountzilas G, Kosmidis PA, Razis E, Georgoulias VA, Nasioulas G. Apessos A, et al. Among authors: kosmidis pa. Br J Cancer. 2005 Jan 31;92(2):396-404. doi: 10.1038/sj.bjc.6602260. Br J Cancer. 2005. PMID: 15655560 Free PMC article.
Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study.
Papakostas P, Tsavdaridis D, Kosmidis P, Kalofonos HP, Sakantamis A, Janinis D, Skarlos D, Bafaloukos D, Bamias A, Xiros N, Fountzilas G. Papakostas P, et al. Among authors: kosmidis p. Gastric Cancer. 2006;9(1):26-31. doi: 10.1007/s10120-005-0353-4. Gastric Cancer. 2006. PMID: 16557433 Clinical Trial.
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group.
Kosmidis PA, Dimopoulos MA, Syrigos K, Nicolaides C, Aravantinos G, Boukovinas I, Pectasides D, Fountzilas G, Bafaloukos D, Bacoyiannis C, Kalofonos HP. Kosmidis PA, et al. J Thorac Oncol. 2007 Feb;2(2):135-40. J Thorac Oncol. 2007. PMID: 17410029 Free article. Clinical Trial.
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study.
Makatsoris T, Papakostas P, Kalofonos HP, Xanthakis I, Tsavdaridis D, Aravantinos G, Gogas H, Klouvas G, Kosmidis P, Pectasides D, Fountzilas G. Makatsoris T, et al. Among authors: kosmidis p. Med Oncol. 2007;24(3):301-7. doi: 10.1007/s12032-007-0004-1. Med Oncol. 2007. PMID: 17873305 Clinical Trial.
264 results